Proteomics as a tool to gain next level insights into photo-crosslinkable biopolymer modifications Related news See all Plateformes et services 20 February 2025 Medicinal Chemistry Platform: Your Partner in Drug Development Communiqués 8 January 2024 The Research Center of CHU de Québec-Université Laval joins forces with Verily, a subsidiary of Alphabet, on research study that seeks to revolutionize dermatology and skin care See all
Plateformes et services 20 February 2025 Medicinal Chemistry Platform: Your Partner in Drug Development
Communiqués 8 January 2024 The Research Center of CHU de Québec-Université Laval joins forces with Verily, a subsidiary of Alphabet, on research study that seeks to revolutionize dermatology and skin care